Drug Profile
Cyclobenzaprine - ALZA Corporation
Alternative Names: Flexeril; Flexeril XL; MK-130; OROS CyclobenzaprineLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator ALZA Corporation
- Class Amines; Analgesics; Anxiolytics; Behavioural disorder therapies; Dibenzocycloheptenes; Drug withdrawal therapies; Muscle relaxants; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Musculoskeletal pain; Spasm
Most Recent Events
- 30 Jul 2010 Generic equivalent available in USA for Spasm
- 30 Oct 2003 Data from a media release have been added to the adverse events and Musculoskeletal Disorders therapeutic trials sections
- 25 Jun 2003 Data from a media release have been added to the Musculoskeletal pain therapeutic trials section